Powered by Google Google ÜbersetzerGoogle Übersetzer
Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Latest Press Releases
View all
TimeHeadline
Just nowAdial Pharmaceuticals Advances IP Portfolio with New U.S. Utility Patent Application, Positioning for Potential Market Exclusivity Through 2045
Just nowCarrier Ventures Expands Investment in ZutaCore to Scale Liquid Cooling for AI Data Centers
1m agoVivoPower to Present at the Emerging Growth Conference
1m agoUsio Announces First Quarter Fiscal Year 2026 Results Conference Call and Company Update on May 13, 2026
1m agoPNC Bank Expands Treasury Management Capabilities with New Property and Casualty Insurance Payments Solution
Upstream Bio, Inc. logo

Upstream Bio, Inc.

About

Upstream Bio, Inc. (NASDAQ:UPB) — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 17 2026
Upstream Bio to Present New Data from Phase 2 VIBRANT Trial of Verekitug at the ATS 2026 International Conference
Mar 26 2026
Upstream Bio Highlights Phase 3 Development Strategy for Verekitug and Reports Fourth Quarter and Full Year 2025 Financial Results
Mar 1 2026
Upstream Bio Presents Additional Analyses from the Phase 2 VIBRANT Trial of Verekitug in Chronic Rhinosinusitis with Nasal Polyps at 2026 AAAAI Annual Meeting
Feb 26 2026
Upstream Bio to Present Additional Analyses from Phase 2 VIBRANT Trial in Chronic Rhinosinusitis with Nasal Polyps in Late-Breaking Session at AAAAI Annual Meeting 2026
Feb 25 2026
Upstream Bio to Participate in Upcoming March Investor Conferences

Financials

Revenue
$2.85 M
Market Cap
$567.06 M
EPS
-2.66

Community Chat

Ask AI

6ix6ixAIEvents